Personalis, Inc.
General ticker "PSNL" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $439.3M (TTM average)
Personalis, Inc. follows the US Stock Market performance with the rate: 56.1%.
Estimated limits based on current volatility of 4.1%: low 9.81$, high 10.66$
Factors to consider:
- Total employees count: 229 (+1.8%) as of 2024
- US accounted for 96.0% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: High operating expenses, Lack of profitability, Labor/talent shortage/retention, Strategic risks and growth management, Regulatory and compliance
- Current price 43.0% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.73$, 7.33$]
- 2025-12-31 to 2026-12-31 estimated range: [1.87$, 5.10$]
Financial Metrics affecting the PSNL estimates:
- Positive: with PPE of -4.1 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -13.58 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: -14.38 < Investing cash flow per share per price, % of -10.55
- Negative: negative Net income
- Negative: negative Industry operating income (median)
- Positive: Shareholder equity ratio, % of 75.09 > 63.39
- Positive: Industry inventory ratio change (median), % of -0.79 <= -0.15
Short-term PSNL quotes
Long-term PSNL plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $65.05MM | $73.48MM | $84.61MM |
| Operating Expenses | $180.58MM | $183.42MM | $152.88MM |
| Operating Income | $-115.53MM | $-109.94MM | $-68.27MM |
| Non-Operating Income | $2.26MM | $1.72MM | $-13.00MM |
| Interest Expense | $0.20MM | $0.11MM | $0.02MM |
| R&D Expense | $64.91MM | $64.78MM | $48.91MM |
| Income(Loss) | $-113.28MM | $-108.21MM | $-81.27MM |
| Taxes | $0.04MM | $0.08MM | $0.02MM |
| Profit(Loss)* | $-113.31MM | $-108.30MM | $-81.28MM |
| Stockholders Equity | $218.14MM | $129.44MM | $202.96MM |
| Inventory | $6.38MM | $5.66MM | $3.98MM |
| Assets | $292.70MM | $225.10MM | $270.27MM |
| Operating Cash Flow | $-70.23MM | $-56.26MM | $-45.15MM |
| Capital expenditure | $49.90MM | $10.91MM | $1.60MM |
| Investing Cash Flow | $52.54MM | $13.10MM | $-35.07MM |
| Financing Cash Flow | $1.37MM | $11.03MM | $114.67MM |
| Earnings Per Share** | $-2.48 | $-2.25 | $-1.37 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.